Profit Taking Continues With Speculative Biotech Stocks Many of you who trade biopharmaceutical stocks know that $1B may be considered a small cap stock. As we mentioned in yesterday’s post there is weakness in many high flying biotech stocks compared to the larger caps. Today the weakness is more pronounced in many “smaller” cap stocks: […]
PO Box 3701
Manhattan Beach CA 90266